We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.51B
AUM Growth
-$404M
Cap. Flow
-$428M
Cap. Flow %
-6.58%
Top 10 Hldgs %
75.64%
Holding
128
New
5
Increased
10
Reduced
80
Closed
2

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$11.9M
2
BABA icon
Alibaba
BABA
+$4.81M
3
HOLX
Hologic
HOLX
+$3.59M
4
HDB icon
HDFC Bank
HDB
+$3.33M
5
BIIB icon
Biogen
BIIB
+$2.36M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$215M
2
V icon
Visa
V
+$93.1M
3
ECL icon
Ecolab
ECL
+$55.1M
4
PM icon
Philip Morris
PM
+$14.8M
5
GILD icon
Gilead Sciences
GILD
+$5.81M

Sector Composition

Rank Sector Weight
1 Financials 30.37%
2 Consumer Discretionary 18.72%
3 Communication Services 15.06%
4 Healthcare 14.55%
5 Materials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$143B
$19.5M 0.3%
579,045
AMGN icon
27
Amgen
AMGN
$210B
$18.9M 0.29%
110,716
DVAX
28
DELISTED
Dynavax Technologies
DVAX
$14.7M 0.23%
742,015
-28,426
-4% -$491K
AGN
29
DELISTED
Allergan plc
AGN
$14.3M 0.22%
85,101
-9,985
-11% -$1.67M
ABBV icon
30
AbbVie
ABBV
$469B
$13.6M 0.21%
143,271
BIIB icon
31
Biogen
BIIB
$30.5B
$13.3M 0.2%
48,586
+7,612
+19% +$2.36M
EW icon
32
Edwards Lifesciences
EW
$49.4B
$12.9M 0.2%
277,179
SHPG
33
DELISTED
Shire pic
SHPG
$11.9M 0.18%
79,613
-7,709
-9% -$1.06M
BMY icon
34
Bristol-Myers Squibb
BMY
$130B
$11.6M 0.18%
183,407
-30,045
-14% -$1.93M
BDX icon
35
Becton Dickinson
BDX
$46.2B
$11.5M 0.18%
+54,279
New +$11.9M
VTRS icon
36
Viatris
VTRS
$20.9B
$11.4M 0.18%
277,026
-39,019
-12% -$1.66M
CELG
37
DELISTED
Celgene Corp
CELG
$11.1M 0.17%
124,470
-53,292
-30% -$5.12M
MRK icon
38
Merck
MRK
$323B
$10.9M 0.17%
210,456
BSX icon
39
Boston Scientific
BSX
$68.8B
$10M 0.15%
367,194
CNC icon
40
Centene
CNC
$30.9B
$10M 0.15%
187,306
LLY icon
41
Eli Lilly
LLY
$1.09T
$9.68M 0.15%
125,120
GKOS icon
42
Glaukos
GKOS
$9.68B
$8.52M 0.13%
276,272
-17,088
-6% -$518K
ALXN
43
DELISTED
Alexion Pharmaceuticals
ALXN
$8.42M 0.13%
75,574
-130
-0.2% -$15.5K
INSM icon
44
Insmed
INSM
$22.7B
$8.39M 0.13%
372,662
-19,345
-5% -$509K
ESRX
45
DELISTED
Express Scripts Holding Company
ESRX
$8.26M 0.13%
119,604
-31,106
-21% -$2.37M
VRTX icon
46
Vertex Pharmaceuticals
VRTX
$124B
$7.89M 0.12%
48,396
-192
-0.4% -$31.4K
HCA icon
47
HCA Healthcare
HCA
$91.1B
$7.71M 0.12%
79,535
-51,083
-39% -$4.96M
JAZZ icon
48
Jazz Pharmaceuticals
JAZZ
$16.2B
$7.49M 0.12%
49,592
-62
-0.1% -$9.1K
CLVS
49
DELISTED
Clovis Oncology, Inc.
CLVS
$7.2M 0.11%
136,348
-33,352
-20% -$1.95M
EXEL icon
50
Exelixis
EXEL
$14.1B
$6.81M 0.1%
307,275
-45,233
-13% -$1.25M

Similar funds

C WorldWide Group's Q1 2018 Portfolio in Review

As of Q1 2018, C WorldWide Group held 128 positions worth $6.51B, down 5.8% from $6.92B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

C WorldWide Group withdrew a net $428M in Q1 2018, closing 2 positions and reducing 80 holdings. Its most notable exit was AutoZone, an estimated $595K position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, C WorldWide Group opened a new position in Becton Dickinson worth $11.5M.

  • C WorldWide Group's largest Q1 2018 buy was Becton Dickinson: 54,279 shares worth $11.5M.
  • C WorldWide Group added most to Alibaba in Q1 2018, an estimated $4.81M increase.
  • C WorldWide Group's biggest Q1 2018 reduction was Booking.com, cutting an estimated $215M.
  • C WorldWide Group fully exited AutoZone in Q1 2018, selling an estimated $595K.
  • C WorldWide Group's ten largest holdings make up 76% of its $6.51B portfolio in Q1 2018.
  • C WorldWide Group opened 5 new positions and closed 2 in Q1 2018.
  • C WorldWide Group's portfolio value fell 5.8% quarter-over-quarter to $6.51B.

Based on C WorldWide Group's 13F filing for Q1 2018, filed 3 May 2018.